| scholarly article | Q13442814 |
| P356 | DOI | 10.2165/00044011-200424030-00004 |
| P698 | PubMed publication ID | 17516702 |
| P2093 | author name string | Gideon Koren | |
| Adrienne Einarson | |||
| Thomas R Einarson | |||
| Anna Taddio | |||
| Heather A Bennett | |||
| P2860 | cites work | Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling | Q24541120 |
| An Inventory for Measuring Depression | Q26778503 | ||
| Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study | Q28239287 | ||
| Neurodevelopment of children exposed in utero to antidepressant drugs | Q28301174 | ||
| Discontinuing antidepressants and benzodiazepines upon becoming pregnant. Beware of the risks of abrupt discontinuation | Q28361654 | ||
| Neurobiology of depression | Q29619932 | ||
| Infant mortality statistics from the 2001 period linked birth/infant death data set | Q30881329 | ||
| Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy | Q31925061 | ||
| Pharmacologic treatment of depression during pregnancy | Q33749995 | ||
| Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. | Q33751894 | ||
| Depressive illness | Q33759114 | ||
| Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire | Q33777234 | ||
| The triad of substance abuse, violence, and depression are interrelated in pregnancy | Q33818303 | ||
| Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies. | Q33866352 | ||
| Are SSRIs safe for pregnant and breastfeeding women? | Q33883960 | ||
| Postpartum depression. | Q34114743 | ||
| Treatment guidelines for depression in pregnancy | Q34123236 | ||
| Antidepressant drugs during pregnancy and lactation | Q34149791 | ||
| Screening for depression across the lifespan: a review of measures for use in primary care settings | Q34152592 | ||
| Recent advances in the neurobiology of depression. | Q34165846 | ||
| Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale | Q34186484 | ||
| Antepartum and postpartum depression | Q34203704 | ||
| Clinical guidelines for the treatment of depressive disorders, I. Definitions, prevalence, and health burden. | Q34301045 | ||
| Clinical guidelines for the treatment of depressive disorders. VI. Special populations | Q34301082 | ||
| Stress and mood disorders during pregnancy: implications for child development | Q34348120 | ||
| Natural history of Diagnostic Interview Schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up | Q34445993 | ||
| Psychotropic medications in pregnant women: treatment dilemmas. | Q34481615 | ||
| Drugs in pregnancy. Pharmacokinetics in pregnancy | Q34500441 | ||
| Teratogenic effects of alcohol on brain and behavior. | Q34505863 | ||
| Risk-benefit decision making for treatment of depression during pregnancy | Q73247015 | ||
| The puzzling association between smoking and hypertension during pregnancy | Q73281516 | ||
| Alcohol consumption among pregnant and childbearing-aged women--United States, 1991 and 1995 | Q73333204 | ||
| Depression in the community: the first pan-European study DEPRES (Depression Research in European Society) | Q73406200 | ||
| Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications | Q73795774 | ||
| Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals | Q73927447 | ||
| The effects of maternal depression on fetal heart rate response to vibroacoustic stimulation | Q74058505 | ||
| Managing depression in pregnancy | Q74065979 | ||
| Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study | Q74327370 | ||
| Moderate alcohol consumption during pregnancy and the incidence of fetal malformations: a meta-analysis | Q74340179 | ||
| Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes | Q74558702 | ||
| Obstetrical complications and the development of postpartum depressive symptoms: a prospective survey of the MATQUID cohort | Q74666029 | ||
| Effects of framing on teratogenic risk perception in pregnant women | Q77053482 | ||
| Prenatal and postnatal depression among low income Brazilian women | Q77069723 | ||
| Fetal exposure to maternal cortisol | Q77206658 | ||
| Incidence and demographic correlates of depressive symptoms during pregnancy in an inner London population | Q77940476 | ||
| Depression: a decade of progress, more to do | Q78604491 | ||
| The impact of prenatal care in the United States on preterm births in the presence and absence of antenatal high-risk conditions | Q44221393 | ||
| Psychosocial correlates of prepartum and postpartum depressed mood | Q44356325 | ||
| Psychosocial assessment and management of depression and anxiety in pregnancy. Key aspects of antenatal care for general practice. | Q44383643 | ||
| Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy | Q44414924 | ||
| Depressive symptoms among pregnant women screened in obstetrics settings | Q44476598 | ||
| Mental disorders associated with childbearing: report of the Biennial Meeting of the Marcé Society. | Q45173922 | ||
| How can care for depression become more cost-effective? | Q45947277 | ||
| The differential effect of prenatal care on the incidence of low birth weight among blacks and whites in a prepaid health care plan. | Q46011130 | ||
| The detection and treatment of psychiatric disorders and substance use among pregnant women cared for in obstetrics. | Q46022421 | ||
| A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. | Q46326672 | ||
| Pregnancy-related mortality from preeclampsia and eclampsia | Q46353535 | ||
| Delivery outcome after the use of antidepressants in early pregnancy | Q46356054 | ||
| Psychiatric and substance use disorders as risk factors for low birth weight and preterm delivery | Q46495635 | ||
| A standardized interview that differentiates pregnancy and postpartum symptoms from perinatal clinical depression | Q46546225 | ||
| Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland | Q46822388 | ||
| The course and outcome of depression in different cultures: 10-year follow-up of the WHO Collaborative Study on the Assessment of Depressive Disorders | Q47251260 | ||
| Epidemiology, burden, and disability in depression and anxiety. | Q47619697 | ||
| Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications | Q47717716 | ||
| Prevalence of suicide ideation and suicide attempts in nine countries | Q47725617 | ||
| Cross-national epidemiology of major depression and bipolar disorder | Q47826731 | ||
| Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study | Q47869465 | ||
| The neurobiology of depression | Q48022224 | ||
| Somatic complaints among pregnant women cared for in obstetrics: normal pregnancy or depressive and anxiety symptom amplification revisited? | Q49036656 | ||
| Recovery in major depressive disorder: analysis with the life table and regression models. | Q50590770 | ||
| Health care costs of primary care patients with recognized depression. | Q50594742 | ||
| Alcohol consumption by pregnant women in the United States during 1988-1995. | Q50633284 | ||
| Comparative incidence of depression in women and men, during pregnancy and after childbirth. Validation of the Edinburgh Postnatal Depression Scale in Portuguese mothers. | Q51008341 | ||
| Point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study. | Q51021763 | ||
| Mood disturbance in pregnancy and the mode of delivery. | Q51036948 | ||
| Effects of antenatal stress and anxiety: Implications for development and psychiatry. | Q51048941 | ||
| Role of anxiety and depression in the onset of spontaneous preterm labor. | Q51055441 | ||
| Patients with psychiatric disorders in gynecologic practice. | Q51063521 | ||
| Depression in Europe: experience from the DEPRES II survey. Depression Research in European Society. | Q51072178 | ||
| Body mass index, eating attitudes, and symptoms of depression and anxiety in pregnancy and the postpartum period. | Q51081441 | ||
| Depression and anxiety in early pregnancy and risk for preeclampsia. | Q51082104 | ||
| Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. | Q51119914 | ||
| The effect of anxiety and depression during pregnancy on obstetric complications. | Q51141295 | ||
| Maternal depressive symptoms during pregnancy, and newborn irritability. | Q51166725 | ||
| Depressive symptoms during pregnancy: relationship to poor health behaviors. | Q51753622 | ||
| Excess mortality in depression: a meta-analysis of community studies. | Q51952074 | ||
| Psychiatric symptoms, functional impairment, and receptivity toward mental health treatment among obstetrical patients. | Q51958049 | ||
| Health-related functional status in pregnancy: relationship to depression and social support in a multi-ethnic population. | Q51966382 | ||
| Maternal life history--versus gestation-focused assessment of prenatal exposure to substances of abuse. | Q51970764 | ||
| The North Staffordshire Maternity Hospital prospective study of pregnancy-associated depression. | Q51973906 | ||
| Plasma norepinephrine and prediction of outcome in major depressive disorder. | Q51980179 | ||
| Treatment of depression by obstetrician-gynecologists: a survey study. | Q51999822 | ||
| Psychological and social correlates of the onset of affective disorders among pregnant women. | Q52032457 | ||
| Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac) | Q52225071 | ||
| Depression in primary care. A nationwide epidemiological survey | Q57005324 | ||
| Antenatal depression, substance dependency and social support | Q59652596 | ||
| The Association Between Adequacy of Prenatal Care Utilization and Subsequent Pediatric Care Utilization in the United States | Q60152524 | ||
| Factorial study of the BDI in pregnant women | Q60634537 | ||
| Prevalence of depressive symptoms in late pregnancy and postpartum | Q61061704 | ||
| Validation of the Edinburgh postnatal depression scale (EPDS) in non-postnatal women | Q64115560 | ||
| The relationship of demographic variables, antepartum depression, and stress to postpartum depression | Q68612752 | ||
| Social support, life events, and depression during pregnancy and the puerperium | Q69505808 | ||
| Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum | Q69737610 | ||
| Intrauterine growth retardation and premature delivery: the influence of maternal smoking and psychosocial factors | Q71009254 | ||
| Birth outcomes in pregnant women taking fluoxetine | Q71504471 | ||
| Treating depression in pregnancy | Q71504495 | ||
| The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS) | Q71585052 | ||
| A meta-analysis of predictors of postpartum depression | Q71591528 | ||
| Pregnancy and psychotropic medication: changes in blood levels | Q71599731 | ||
| Screening for depression in pregnancy: characteristics of the Beck Depression Inventory | Q71832919 | ||
| Lower risk of suicide during pregnancy | Q71958006 | ||
| Depression in women: implications for health care research | Q71967766 | ||
| Chronic stressors, social support, and depression during pregnancy | Q72650263 | ||
| Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study | Q72821316 | ||
| Tricyclic dose requirements across pregnancy | Q72938944 | ||
| Controlled clinical trial of interpersonal psychotherapy versus parenting education program for depressed pregnant women | Q73067130 | ||
| Birth outcomes following prenatal exposure to fluoxetine | Q73200043 | ||
| Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study | Q34518006 | ||
| Is this patient clinically depressed? | Q34552378 | ||
| Depression during pregnancy: diagnosis and treatment options | Q34627758 | ||
| Revision of the postpartum depression predictors inventory | Q34765835 | ||
| Benefits and risks of psychiatric medications during pregnancy | Q34802921 | ||
| Theoretical perspectives of postpartum depression and their treatment implications | Q34810066 | ||
| Outcomes of prenatal antidepressant exposure | Q35008993 | ||
| Recent developments in the psychobiology and pharmacotherapy of depression: optimising existing treatments and novel approaches for the future | Q35040802 | ||
| Birth outcomes after prenatal exposure to antidepressant medication | Q35084565 | ||
| A prospective study of smoking during pregnancy and SIDS. | Q35267469 | ||
| Bacterial vaginosis during pregnancy. Should we screen for and treat it? | Q36405785 | ||
| Update on motherisk updates. Seven years of questions and answers. | Q36405911 | ||
| Cohort study of depressed mood during pregnancy and after childbirth | Q36500545 | ||
| Fetal alcohol syndrome. Role of the family physician | Q36514787 | ||
| Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women | Q38458208 | ||
| Adequacy of prenatal care among women with psychiatric diagnoses giving birth in California in 1994 and 1995. | Q38466648 | ||
| Depression prevalence and incidence among inner-city pregnant and postpartum women | Q39374130 | ||
| Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring | Q39407335 | ||
| Mood disorders: rural/urban differences in prevalence, health care utilization, and disability in Ontario | Q39426855 | ||
| Common mental disorders in Santiago, Chile: prevalence and socio-demographic correlates | Q39560247 | ||
| Psychosocial factors and pregnancy outcome: a review with emphasis on methodological issues | Q40377240 | ||
| Women at risk for postpartum-onset major depression | Q40465599 | ||
| The impact of prenatal care on postneonatal deaths in the presence and absence of antenatal high-risk conditions | Q40570655 | ||
| The Expert Consensus Guideline Series. Treatment of depression in women. | Q40692025 | ||
| Predictors, prodromes and incidence of postpartum depression | Q40697956 | ||
| Depression in the workplace: effects on short-term disability | Q40796640 | ||
| Course of mood and anxiety disorders during pregnancy and the postpartum period | Q40861973 | ||
| Maternal depressive symptoms and the risk of poor pregnancy outcome. Review of the literature and preliminary findings | Q40923254 | ||
| Ethically justified clinically comprehensive guidelines for the management of the depressed pregnant patient | Q40951931 | ||
| Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines | Q40979339 | ||
| Self-reported depression and negative pregnancy outcomes | Q41106128 | ||
| The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression | Q41323343 | ||
| Paternal and maternal depressed mood during the transition to parenthood | Q43581985 | ||
| Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors | Q43594806 | ||
| Evidence based information on drug use during pregnancy: a survey of community pharmacists in three countries | Q43643984 | ||
| The role of acetaldehyde in pregnancy outcome after prenatal alcohol exposure | Q43690645 | ||
| Trends in alcohol consumption by pregnant women. 1985 through 1988. | Q43705452 | ||
| Obstetricians and maternal body weight and eating disorders during pregnancy | Q43762105 | ||
| Foetal alcohol syndrome--a multifaceted condition | Q43888530 | ||
| SSRIs in pregnancy--are they safe? | Q43937277 | ||
| Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response. | Q43937289 | ||
| The prevalence of psychiatric morbidity and its associated factors in general health care in Taiwan. | Q44053112 | ||
| Moderate smoking during pregnancy is associated with a reduced risk of preeclampsia. | Q44097616 | ||
| Citalopram in pregnancy and lactation | Q44110140 | ||
| Management of major depression during pregnancy | Q44164480 | ||
| Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study | Q44201496 | ||
| Perinatal outcome following third trimester exposure to paroxetine | Q44202785 | ||
| P433 | issue | 3 | |
| P921 | main subject | depression during pregnancy | Q2253120 |
| P304 | page(s) | 157-179 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Clinical Drug Investigation | Q15753215 |
| P1476 | title | Depression during Pregnancy : Overview of Clinical Factors | |
| P478 | volume | 24 |
| Q37008530 | A Thematic Analysis of Stigma and Disclosure for Perinatal Depression on an Online Forum |
| Q33942240 | A meta-analysis of treatments for perinatal depression |
| Q37634873 | Adherence of antidepressants during pregnancy: MEMS compared with three other methods |
| Q36779157 | Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension |
| Q30834231 | Becoming the best mom that I can: women's experiences of managing depression during pregnancy--a qualitative study |
| Q37197207 | Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 6. Special Populations: Youth, Women, and the Elderly. |
| Q90029502 | Challenges to the parental brain: Neuroethological and translational considerations |
| Q35718651 | Clomipramine concentration and withdrawal symptoms in 10 neonates |
| Q34158215 | Depressive symptoms and birth outcomes among pregnant teenagers |
| Q48358069 | Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling |
| Q36147188 | Factors Affecting Depression During Pregnancy and the Correlation Between Social Support and Pregnancy Depression |
| Q34432414 | Household food insecurity is associated with depressive symptoms among low-income pregnant Latinas |
| Q37190382 | In utero exposure to antidepressant drugs and risk of attention deficit hyperactivity disorder: a nationwide Danish cohort study |
| Q45949600 | Infant health and neurodevelopmental outcomes following prenatal exposure to duloxetine. |
| Q24200935 | Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression |
| Q24241027 | Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression |
| Q36328078 | Interventions to treat mental disorders during pregnancy: A systematic review and multiple treatment meta-analysis |
| Q34143400 | Oxytocin and postpartum depression: delivering on what's known and what's not. |
| Q33845368 | Partner relationship satisfaction and maternal emotional distress in early pregnancy |
| Q44225620 | Prenatal depression in Latinas in the U.S. and Mexico. |
| Q36129909 | Prevalence and Predictors of Depression among Pregnant Women in Debretabor Town, Northwest Ethiopia |
| Q24243981 | Psychosocial and psychological interventions for treating antenatal depression |
| Q37635225 | Risks of untreated depression in pregnancy |
| Q58896814 | Schwangerschaftsdepression und deren Behandlung |
| Q48897179 | Stress and the pregnant female: Impact on hippocampal cell proliferation, but not affective-like behaviors. |
| Q34808949 | Tailoring treatment of depression for women across the reproductive lifecycle: the importance of pregnancy, vasomotor symptoms, and other estrogen-related events in psychopharmacology. |
| Q36251309 | The Impact of Antenatal Depression on Perinatal Outcomes in Australian Women |
| Q34134417 | The buffering effect of relationship satisfaction on emotional distress in couples |
| Q38672603 | The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies |
| Q35090232 | The increasing burden of depression |
| Q34192437 | The utility of screening for perinatal depression in the second trimester among Chinese: a three-wave prospective longitudinal study |
| Q24616602 | Use of antidepressants during pregnancy and the risk of spontaneous abortion |
| Q37065238 | Use of selective serotonin reuptake inhibitors and lifestyle among women of childbearing age: a Danish cross-sectional survey |
| Q36253673 | Using the Patient Health Questionnaire (PHQ-9) and the Edinburgh Postnatal Depression Scale (EPDS) to assess suicidal ideation among pregnant women in Lima, Peru |
Search more.